# Base Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/base-genomics

- Industry: Biotechnology
- Headquarters: Oxford, UK
- Website: www.basegenomics.com
- Total disclosed funding: $12M
- Latest round: Seed (May 21, 2020)
- Investors on record: 1

## About

Base Genomics Ltd is a biotechnology company focused on developing advanced DNA sequencing technologies to enhance genomic analysis and precision medicine solutions.Base Genomics Ltd, founded in 2019, is an Oxford, UK-based biotech firm specializing in innovative DNA sequencing technologies. The company was acquired by Exact Sciences Corporation in October 2020 for USD 410 mn. The deal reflects their commitment to enhancing genomic analysis capabilities. No significant changes in business operations or strategy have been noted since its founding.Base Genomics Ltd offers cutting-edge DNA sequencing technologies aimed at improving precision medicine and genomic analysis. Their products are designed to cater to a range of stakeholders in the healthcare and research sectors, primarily focusing on providing reliable and accurate genomic data to facilitate better patient outcomes.In 2023, Base Genomics Ltd reported a revenue of USD 1,544,551 with an EBITDA of USD -7,404,444, indicating an operational loss while still generating revenue during that year.Following the acquisition by Exact Sciences Corporation, Base Genomics Ltd plans to leverage its resources to expand its product offerings and enhance its market presence. Future initiatives include the launch of new genomic analysis tools and expansion into international markets, aiming for a broader reach in North America and Europe. The recent acquisition funding of USD 410 mn will be instrumental in supporting these growth initiatives.

## Funding rounds

- Seed, May 21, 2020, $12M — Oxford Sciences Enterprises

## Investors

- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Seed